Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate and Severe COVID-19”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04902183
What this trial is testing

Safety and Efficacy of Exosomes Overexpressing CD24 in Two Doses for Patients With Moderate or Severe COVID-19

Who this might be right for
Covid19
Athens Medical Society 90
Large-scale testing (Phase 3)Ended earlyNCT04421508
What this trial is testing

Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19

Who this might be right for
COVID-19CoronavirusCoronavirus Infection
Bellerophon Pulse Technologies 191
Not applicableUnknownNCT05165979
What this trial is testing

Cohort Study for the Assessment of Long-term Impact of COVID-19 Among Moderate and Severe COVID-19 Patients in Brazil

Who this might be right for
COVID-19Quality of LifeDisability Physical+1 more
Hospital Moinhos de Vento 650
Not applicableStudy completedNCT04664010
What this trial is testing

Efficacy and Safety of High-dose Vitamin C Combined With Chinese Medicine Against Coronavirus Pneumonia (COVID-19)

Who this might be right for
COVID-19
Xi'an International Medical Center Hospital 30
Early research (Phase 1)Temporarily pausedNCT05387278
What this trial is testing

Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19)

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeRespiratory Distress Syndrome
Vitti Labs, LLC 20
Large-scale testing (Phase 3)Ended earlyNCT04695704
What this trial is testing

Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19:

Who this might be right for
Covid19SARS (Disease)
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 86
Large-scale testing (Phase 3)Study completedNCT04494984
What this trial is testing

Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.

Who this might be right for
COVID-19
Inmunova S.A. 243
Large-scale testing (Phase 3)WithdrawnNCT04575064
What this trial is testing

An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY

Who this might be right for
SARS-CoV-2 InfectionCOVID-19Moderate and Severe COVID-19
Professor Dr. Bernd Mühlbauer
Not applicableStudy completedNCT04667936
What this trial is testing

Evaluation of Sedation in COVID-19 ARDS

Who this might be right for
Prone PositionSevere Acute Respiratory Syndrome Coronavirus 2Hypnotics and Sedatives+1 more
Goethe University 114
Testing effectiveness (Phase 2)WithdrawnNCT04830735
What this trial is testing

Dasatinib for the Treatment of Moderate and Severe COVID-19

Who this might be right for
Symptomatic COVID-19 Infection Laboratory-Confirmed
University of Southern California
Testing effectiveness (Phase 2)Ended earlyNCT05156671
What this trial is testing

Adrecizumab (HAM8101) to Improve Prognosis and Outcomes in COVID-19 Trial

Who this might be right for
COVID-19
Universitätsklinikum Hamburg-Eppendorf 16
Large-scale testing (Phase 3)Ended earlyNCT04492358
What this trial is testing

Treatment for Moderate/Severe COVID-19 in a Fragile and Vulnerable Population, Admitted to a Geriatric Hospital Unit or in a Transicional Care Center

Who this might be right for
Covid19
Maria Joyera Rodríguez 54
Large-scale testing (Phase 3)UnknownNCT04610541
What this trial is testing

REMdesivir-HU Clinical Study and Severe Covid-19 Patients

Who this might be right for
SARS-CoV-2 Infection
University of Pecs 2,000
Post-approval studies (Phase 4)UnknownNCT04359615
What this trial is testing

Favipiravir in Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
Shahid Beheshti University of Medical Sciences 40
Testing effectiveness (Phase 2)UnknownNCT04969172
What this trial is testing

A Phase II Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Exosomes Overexpressing CD24 to Prevent Clinical Deterioration in Patients With Moderate or Severe COVID-19 Infection

Who this might be right for
COVID-19 Disease
Eli Sprecher, MD 155
Testing effectiveness (Phase 2)Study completedNCT04533347
What this trial is testing

Tafenoquine in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID 19 Disease
60 Degrees Pharmaceuticals LLC 86
Testing effectiveness (Phase 2)UnknownNCT04338802
What this trial is testing

Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19

Who this might be right for
COVID-19NintedanibSafety+1 more
Huilan Zhang 96
Testing effectiveness (Phase 2)WithdrawnNCT05085574
What this trial is testing

Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)

Who this might be right for
2019 Novel Coronavirus Disease2019 Novel Coronavirus Infection2019-nCoV Disease+9 more
Leidos Life Sciences
Not applicableStudy completedNCT04392973
What this trial is testing

FAvipiravir and HydroxyChloroquine Combination Therapy

Who this might be right for
COVID19
King Abdullah International Medical Research Center 268
Large-scale testing (Phase 3)Ended earlyNCT04403685
What this trial is testing

Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers

Who this might be right for
COVIDSARS PneumoniaCytokine Release Syndrome
Beneficência Portuguesa de São Paulo 129
Next Page